North Korea vs Mus: Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC
North Korea
99.0%
in 2025
Mus
93.0%
in 2025
North Korea rank
1st
Mus rank
1st
Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC over time
- North Korea
- Mus
How they compare
North Korea currently reports 99.0% against 93.0% in Mus, a difference of 6.0%.
That makes North Korea's figure about 1.1 times Mus's.
The two have swapped places 3 times across 26 shared years of data; in 2000 it was Mus ahead.
North Korea ranks 1st and Mus ranks 1st of 194 countries.
Across the 3 decades both report, North Korea averaged higher in 1 and Mus in 2.
Head to head by decade
| Decade | North Korea | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.0% | 49.1% | 34.1% | Mus |
| 2010s | 85.8% | 92.0% | 6.2% | Mus |
| 2020s | 99.0% | 94.5% | 4.5% | North Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, North Korea or Mus?
- North Korea, at 99.0% against 93.0% in Mus as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between North Korea and Mus?
- 6.0%, with North Korea ahead.
- How many years of comparable data are there for North Korea and Mus?
- 26 years are reported by both, from 2000 to 2025.
- How do North Korea and Mus rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- North Korea ranks 1st and Mus ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.